Neuronetrix announced that has begun a multicenter clinical trial of its Cognision system for the early detection of Alzheimer’s. The product works by measuring electrical field potentials of the brain while a sound pattern is played to the subject. Findings are then compared to a database of earlier recordings, the firm notes.
http://www.neuronetrix.com/